NEWSNATIONNOW (Rob Taub) - More US employers dropping coverage for weight-loss drugs in 2027
Demand for Ozempic, Wegovy and similar drugs is soaring, but some employers say the cost is becoming too much to absorb.
Demand for Ozempic, Wegovy and similar drugs is soaring, but some employers say the cost is becoming too much to absorb.
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won't cover it, you have options.
Next month's launch of a Medicare program providing weight-loss drugs for $50 a month is expected to unleash pent-up demand for Wegovy, Zepbound and other blockbuster treatments — and create new bottlenecks at doctors' offices. The big picture: It could become one of the biggest drug rollouts ever — and it could test an already burdened system as seniors seek new GLP-1 prescriptions. - Clinicians worry that could also give short shrift to patient counseling on how to take the injectables and pills, adjust dosages and deal with side effects. - Medicare has been prohibited by law from covering weight-loss drugs. Where it stands: The new program is part of a deal President Trump struck with Eli Lilly and Novo Nordisk to cut prices for…